德克斯公司推出FDA批准的非处方连续血糖监测器Stelo,用于2型糖尿病的成年人. Dexcom launches FDA-approved over-the-counter continuous glucose monitor Stelo for adults with type 2 diabetes.
德克斯公司推出了Stelo,这是FDA批准的第一款无处方连续血糖监测器, Dexcom has launched Stelo, the first FDA-approved over-the-counter continuous glucose monitor, available without a prescription. 针对没有使用胰岛素的18岁及以上2型糖尿病患者, 两包Stelo每月99美元, 可长达15天使用. Targeted at adults 18 and older with type 2 diabetes who don't use insulin, Stelo costs $99 per month for a two-pack and can be worn for up to 15 days. 它连接到智能电话应用程序, 每15分钟提供葡萄糖读数, 增加没有保险的人的上网机会。 It connects to a smartphone app to provide glucose readings every 15 minutes, increasing access for those without insurance coverage.